“…Unlike cisplatin, nonetheless, only a single bond can be formed with DNA, as in such drugs only one labile ligand is bound to the metal center, and due to additional interactions and steric hindrance, cellular repair ability via transcription is reduced and apoptosis is induced with a different mechanism. , Aiming at enhancing the efficacy of monofunctional anticancer agents, dual-action complexes have been designed by appending a suitable photosensitizer (PS) to the ligand bound to platinum(II). Two-component systems of this kind have recently received increasing attention due to the possibility to combine the DNA cross-linking ability of the complex bearing a labile anionic ligand, generally a chloride, with the photodynamic therapy (PDT) effect of a PS. − PDT is an alternative treatment for the control of malignant diseases based on the uptake of a photosensitizing molecule which, upon being excited by light of proper wavelength, reacts with oxygen and generates oxidant species in target tissues, leading to cell death. , The PS, in the photodynamic process, is promoted from its ground singlet state to an excited one. The excitation is followed by an intersystem crossing (ISC) transition to a lower triplet state, being a usually forbidden nonradiative process that can take place if the relativistic spin–orbit coupling (SOC) between the two states is large enough and the involved states are close in energy to permit the process to be efficient.…”